China Isotope & Radiation stock | 2026 price target, earnings & valuation

China Isotope & Radi...

SEHK:1763

HK$ 21,10

+ HK$0,52 (2,53%)

21,10 HK$

+HK$0,52 (2,53%)

End-of-day quote: 03/27/2026

China Isotope & Radiation Stock Value

Currently, analysts rate SEHK:1763 as sf_Data Unavailable.

China Isotope & Radiation Company Info

EPS Growth 5Y

6,03%

Market Cap

HK$6,58 B

Long-Term Debt

HK$1,65 B

Annual earnings

03/27/2026

Dividend

HK$0,44

Dividend Yield

2,07%

Founded

1983

Industry

Materials

Country

China

Website

China Isotope & Radiation

ISIN Number

CNE1000031F4

Website

http://www.china-isotope.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, China Isotope & Radiation’s Price Target has risen from HK$20,59 to HK$20,59 - a 0,00% increase.

Top growth stocks in the materials sector (5Y.)

What does China Isotope & Radiation do?

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. The company plays a critical role in several sectors, including the nuclear energy sector, healthcare, and scientific research. The company emphasizes technological innovation and sustainable development, contributing both to local and global advancements in medical technolo...

The company also aims to provide high-quality products and services tailored to meet the diverse needs of its customers, which include hospitals, research institutions, and regulatory bodies. By leveraging advanced technologies and expertise, the company seeks to enhance patient safety and improve treatment efficiencies through the use of isotopes in various medical applications.

Business Segments

The company operates through various business segments that cater to the specific needs of its clients within the isotopes and radiation field. The company's business segments are structured around the production, research, and application of isotopes, with subtleties defined by distinct market requirements.

Medical Isotope Production

This segment is dedicated to the creation and distribution of medical isotopes utilized in diagnostics and treatments, often for cancer and other serious conditions. Through advanced technology and rigorous testing, the company produces isotopes that are used in radiotherapy and imaging techniques.

Radiopharmaceutical Development

This segment focuses on developing radiopharmaceuticals, which combine radioactive isotopes with drugs to improve diagnosis and therapeutic processes. The company engages in collaborations for research and the clinical application of these items to ensure effective treatments.

Industrial Applications

The company extends its capabilities to industrial applications where radiation technology is utilized for safety, metrology, and equipment sterilization. This segment also invests in technologies geared towards the nuclear industry, focusing on ensuring compliance with safety and performance standards.

Consulting and Training

Understanding the complexity involved in the use of isotopes and radiation technology, the company also offers consulting services to other enterprises and institutions aimed at optimizing isotope usage, meeting regulatory requirements, and enhancing safety standards.

Business Strategy

The company adopts a multifaceted business strategy that emphasizes innovation, quality, and collaboration. The company's strategic direction revolves around expanding its market footprint while maintaining a commitment to sustainability and regulatory compliance.

The cornerstone of this strategy is innovation, where the company continuously invests in research and development to enhance existing products and create novel solutions in the isotope and radiation field. By focusing on cutting-edge technologies, it aims to improve efficacy and safety within the medical field, ensuring that clients have access to the latest advancements in radiopharmaceuticals and diagnostics.

In parallel to innovation, the company places a high premium on quality control processes, which are vital for maintaining high standards in production and service delivery. This includes adhering to international regulations and maintaining certifications that assure clients of the safety and effectiveness of its products.

Products and Services

The company offers a comprehensive array of products and services tailored to meet the needs of various sectors, particularly in healthcare and industrial applications. This portfolio is designed to maximize user benefits while adhering to the highest safety and regulatory standards.

Medical Isotopes

The company specializes in producing a variety of medical isotopes, which are pivotal in diagnostic imaging and therapeutic procedures. Some commonly supplied isotopes include Technetium-99m, Iodine-131, and Palladium-103, among others. These isotopes are widely used in PET and SPECT scans, allowing for non-invasive assessment of medical conditions.

Radiopharmaceuticals

The company is engaged in the development and manufacturing of radiopharmaceuticals that combine radioisotopes with pharmacologically active components. These products are designed to enhance the effectiveness of treatments for conditions such as cancer and thyroid diseases, thereby improving patient outcomes.

Radiation Safety Equipment

To supplement its offerings, the company provides a range of radiation protection equipment tailored for medical, industrial, and research environments. This includes protective gear and instrumentation designed to minimize exposure while ensuring safety and compliance.

Research Services

In addition to isotope production, the company provides consulting and laboratory services focused on radiation technology applications. These services include product testing and analysis, compliance assessments, and safety audits to ensure adherence to industry regulations.

Clinical Training and Support

Understanding the complexities of utilizing isotopes and radiological techniques, the company offers extensive training services aimed at healthcare professionals. This includes workshops and seminars that cover safe handling and administration practices, thereby promoting patient safety.

Geographical Markets Served

The company serves a broad array of geographical markets encompassing the People's Republic of China and extends its outreach to international clients. This strategic approach allows the company to tap into both domestic growth opportunities and global markets that require advanced isotopic and radiation technology.

Seasonality

The company experiences minimal seasonality in its operations. The demand for medical isotopes and radiation technologies remains relatively stable throughout the year, driven by consistent healthcare needs and regulatory requirements. While some fluctuations may occur due to specific healthcare events, these do not significantly impact the overall operational effectiveness of the company. The primary focus remains on steady supply chains and ensuring compliance with safety standards at all times.

Customers

The company serves a diverse clientele that spans various sectors, predominantly in healthcare and industrial applications. The customer base primarily includes hospitals, research institutions, academia, and industrial entities requiring radiological solutions.

While specific customer names are not disclosed, the company maintains relationships with leading institutions and organizations that substantiate its standing in the market. The estimated number of customers served by the company includes hundreds of healthcare providers and research entities that rely on its high-quality products and services.

Sales and Marketing

The company employs a multi-channel approach to marketing and distribution, tailoring strategies to cater to the specific needs of different industries. The marketing modalities emphasize building strong professional relationships with healthcare providers, regulatory bodies, and research institutions.

The company utilizes digital marketing strategies, combined with traditional face-to-face interactions, to enhance its brand visibility within the isotope sector. This dual approach allows the company to effectively communicate its product offerings and the value they bring to their users.

Distribution channels are designed to ensure that products reach customers efficiently while adhering to regulatory requirements. The company works closely with logistics partners specializing in hazardous materials, thereby ensuring safe and compliant delivery.

History

China Isotope & Radiation Corporation was founded in 1983. The company was incorporated in 1983.

China Isotope & Radiation Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Medical isotopes:** approx. 40% **Radiation therapy:** approx. 30% **Radiation protection products:** approx. 20% **Other segments:** approx. 10% **TOP 3 Markets:** 1. **China:** approx. 60% 2. **Asia-Pacific (excluding China):** approx. 20% 3. **Europe:** approx. 15% China Isotope &amp...

At which locations are the company’s products manufactured?

**Production Sites:** Several sites in China China Isotope & Radiation Corporation (CIRC) mainly produces its products in China. The company operates multiple production facilities in the country that specialize in the manufacturing of radioactive isotopes and radiation technology. These sites...

What strategy does China Isotope & Radiation pursue for future growth?

**Strategy for Future Growth:** 1. **Expansion of Production Capacities:** China Isotope & Radiation Corporation plans to expand its production capacities for medical isotopes and radiopharmaceutical products. This will be achieved through the construction of new production facilities and the m...

Which raw materials are imported and from which countries?

**Main raw materials:** Uranium, Cobalt-60, Iridium-192 **Countries of origin:** Canada, Kazakhstan, Russia China Isotope & Radiation Corporation (CIRC) mainly imports radioactive isotopes and materials needed for medical and industrial applications. Uranium is an essential raw material used...

How strong is the company’s competitive advantage?

**Market Share:** 40% (estimated, 2026) **R&D Expenses:** 8% of revenue (2025) **Industry Growth:** 6% annually (2026) China Isotope & Radiation Corporation (CIRC) has a significant competitive advantage that consists of several factors. The company holds an estimated market share of 40...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 45% (estimated, 2026) **Insider Buys/Sells:** No significant transactions in the last year (2026) The institutional investor share in China Isotope & Radiation Corporation is estimated to be around 45%. This suggests that a significant number of shares are hel...

What percentage market share does China Isotope & Radiation have?

**Market share of China Isotope & Radiation Corporation:** 18% (2026, estimated) **Top competitors and their market shares:** 1. **China National Nuclear Corporation (CNNC):** 25% 2. **Shanghai Atom Corporation:** 20% 3. **Beijing Nuclear Technology Co.:** 15% 4. **Sino Radiation Technologies:*...

Is China Isotope & Radiation stock currently a good investment?

**Revenue growth:** 8.5% (2025) **Profit growth:** 10.2% (2025) **Market share in the industry:** 30% (estimated, 2025) China Isotope & Radiation Corporation (CIRC) shows solid revenue and profit growth, indicating strong operational performance and effective cost control. The company benefits...

Does China Isotope & Radiation pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.5% (2026, estimated) **Dividend History:** Continuous payout over the last 5 years China Isotope & Radiation Corporation has been paying a consistent dividend in recent years. The dividend yield is currently estimated at 3.5%, which can be considered solid compared to ot...

New support ticket

Explore

China Isotope & Radiation Stock Value

China Isotope & Radiation Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does China Isotope & Radiation do?

China Isotope & Radiation Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

China Isotope & Radiation Stock Value

China Isotope & Radiation Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does China Isotope & Radiation do?

China Isotope & Radiation Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.